Antibodies to angiogenesis inhibiting domains of CD148

Details for Australian Patent Application No. 2005250341 (hide)

Owner Amgen Inc.

Inventors Smothers, James F.; Fanslow, William C. III; Kariv, Revital

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005250341

PCT Pub. Number WO2005/118643

Priority 60/585,686 06.07.04 US; 60/564,885 23.04.04 US

Filing date 21 April 2005

Wipo publication date 15 December 2005

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/118643 Priority application(s): WO2005/118643

18 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005250346-Wet-laid tissue sheet having an air-laid outer surface

2005250336-Arylsulfonamides and uses as hydroxysteroid dehydrogenase